Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07828639) titled 'A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Condition:
Non-Segmental Vitiligo
Intervention:
Drug: VC005 tablets
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: September 25, 2026
Target Sample Size: 10
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07828639
...